InspireMD to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business Update on Tuesday, February 19

Conference Call Scheduled for 8am Eastern Time

Tel Aviv, Israel— February 7, 2019 – InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, February 19, 2019, to discuss financial results for the three and twelve months ended December 31, 2018, and provide a corporate update.


Conference Call & Webcast:

Tuesday, February 19 @ 8:00am Eastern Time

Within the US:                                   877-451-6152

Outside the US:                                 201-389-0879

Israel:                                                    1 809 406 247

Conference ID:                                  13687159



Replays, Available through March 5th:                    

Domestic:                                            844-512-2921

International:                                    412-317-6671

Replay PIN:                                         13687159


About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.


InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS.



Investor Contacts:

Craig Shore

Chief Financial Officer

InspireMD, Inc.



Jeremy Feffer

LifeSci Advisors, LLC